中文摘要:
中風的醫(yī)療負擔超出了腦損傷本身,很大程度上是由繼發(fā)性慢性合并癥決定的。我們假設(shè)這些合并癥可能有一個共同的免疫學原因,但中風后對全身免疫的慢性影響尚未得到充分探索。在這里,我們將髓系先天免疫記憶確定為中風后遠端器官功能障礙的原因。單細胞測序顯示,在腦損傷后長達 3 個月的多個器官(尤其是心臟)中,單核細胞/巨噬細胞持續(xù)存在促炎變化,導(dǎo)致小鼠和中風患者的心臟纖維化和功能障礙。IL-1β被確定為先天免疫記憶表觀遺傳變化的關(guān)鍵驅(qū)動因素。這些變化可以移植到幼稚小鼠身上,誘發(fā)心功能障礙。通過中和中風后的IL-1β或用CCR2/5抑制劑阻斷促炎性單核細胞運輸,我們預(yù)防了中風后心功能不全。這種免疫靶向療法有可能預(yù)防各種IL-1β介導(dǎo)的合并癥,為二級預(yù)防免疫療法提供框架。
英文摘要:
The medical burden of stroke extends beyond the brain injury itself and is largely determined by chronic comorbidities that develop secondarily. We hypothesized that these comorbidities might share a common immunological cause, yet chronic effects post-stroke on systemic immunity are underexplored. Here, we identify myeloid innate immune memory as a cause of remote organ dysfunction after stroke. Single-cell sequencing revealed persistent pro-inflammatory changes in monocytes/macrophages in multiple organs up to 3 months after brain injury, notably in the heart, leading to cardiac fibrosis and dysfunction in both mice and stroke patients. IL-1β was identified as a key driver of epigenetic changes in innate immune memory. These changes could be transplanted to naive mice, inducing cardiac dysfunction. By neutralizing post-stroke IL-1β or blocking pro-inflammatory monocyte trafficking with a CCR2/5 inhibitor, we prevented post-stroke cardiac dysfunction. Such immune-targeted therapies could potentially prevent various IL-1β-mediated comorbidities, offering a framework for secondary prevention immunotherapy.
論文信息:
論文題目:Innate immune memory after brain injury drives inflammatory cardiac dysfunction
期刊名稱:Cell
時間期卷:在線2024-7-22pages685–700 (2024)
在線時間:2024年7月22日
研究亮點:
- 急性的腦缺血導(dǎo)致持續(xù)的先天免疫記憶
- 先天免疫記憶導(dǎo)致慢性中風后心功能不全
- IL-1β通過表觀遺傳修飾誘導(dǎo)中風后免疫
- 阻斷 IL-1β 或單核細胞募集可預(yù)防心功能不全
材料方法:
靶點科技(北京)有限公司
地址:中關(guān)村生命科學園北清創(chuàng)意園2-4樓2層
© 2024 版權(quán)所有:靶點科技(北京)有限公司 備案號:京ICP備18027329號-2 總訪問量:256887 站點地圖 技術(shù)支持:化工儀器網(wǎng) 管理登陸